A pioneering study pulsed by Oxford University and Barcelona Autonomous University researchers has concluded that the Pfizer vaccine has reduced the mortality rate of residents by 98%, and 97% the probability of being hospitalized after the second dose.
The study, which publishes the scientific journal ‘The Lancet’, is the first global work on the clinical efficacy of the Pfizer vaccine in geriatricians and demonstrates that the effect on workers in residences has reached a level of 95 levels % in sanitarios, del 92% in personal resident, y del 88% in ancianos.
The study, in which the autonomous governor of Catalonia (north) also participates, is established, among others, by the chair of the Center for Medicine at the University of Oxford, Daniel Prieto-Alhambra; the secretary of Salud Pública de Cataluña, Josep Maria Argimon; and the person in charge of evacuation in Catalonia, Carmen Cabezas.
In addition, the article specifies that the first dose generates an infection reduction of between 50 and 60% in all studied students, and as Daniel Prieto-Alhambra has signed a radio broadcast.
The study sample includes 28,594 residents of Catalonia, 26,238 employees of these centers and 61,951 health workers.
Asimismo, the investigators explain that, although the vacancies have demonstrated the efficacy in clinical trials, but more investigations have been made into routine and group populations habitually only represented in the study samples.
For another lad, the matizan results that, analyzing the dates of the first 12 days after the first evacuation, a period in which the dose should not have a significant effect, also recorded reductions of 15 to 20% in infections, which have to be otherwise factors not controlled that influence the phenomenon.
However, the study results in the final results being a follow-up of two months and, in each case, the model will be studied to obtain new results at a large place in the future.
The investigators recall that the conclusions “should be applied to the population on the main benefits associated with the Spanish holiday and other holiday camps”.
The study also cites other works with similar results, as a lifeline to Scotland in general population, with a reduction of between 85 and 94% in the risk of infection, and another in England over hospital staff, which showed a reduction of 72% in infections with a single dose.
For its part, Daniel Prieto-Alhambra has ensured that the results are important because “we think we have the capacity to reduce the number of cases in the residences and the communal transmission”.
The chairman congratulated himself on the results: “It’s spectacular; it’s graphic water that repeats three times to make sure it’s not equipped.”
Prieto-Alhambra has also said that, given the dates of the first doses, “if the second dose of the three recommended doses is increased at the same time as the risk of infection is low”.